drugset
drugset / Trial / NCT04233424

D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection

NCT04233424 ↗

Phase 3 Completed 977 enrolled PolyPid Ltd.
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to assess Efficacy and Safety of D-PLEX Administered Concomitantly with the Standard of Care (SoC), compared to a SoC treated control arm, in prevention of post abdominal surgery incisional infection.

Timeline

Start
2020-06-24
Primary completion
2022-09-02
Completion
2022-09-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 54.6 mg Other

Indications

No indication recorded.